Alkem Laboratories, India's fifth largest pharmaceutical company by market share, is coming out with its initial public offer (IPO). Besides India, Alkem has also spread its sales network in the international arena building a sizeable business in the world’s largest pharmaceutical market, the US. While the company’s impressive growth rates in the domestic market continues, its US business should also grow over time. The company is also making efforts to grow its chronic product portfolio.